Mangalam Drugs and Organics Ltd (MANGALAM) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 138636,
    "name": "Mangalam Drugs",
    "stock_name": "Mangalam Drugs",
    "full_name": "Mangalam Drugs and Organics Ltd",
    "name_url": "stocks-analysis/mangalam-drugs",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "24.01",
    "chg": -0.29,
    "chgp": "-1.19%",
    "dir": -1,
    "prev_price": "24.30",
    "mcapval": "40.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532637,
    "symbol": "MANGALAM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE584F01014",
    "curr_date": "Dec 19",
    "curr_time": "",
    "bse_nse_vol": "90.79 k",
    "exc_status": "Active",
    "traded_date": "Dec 19, 2025",
    "traded_date_str": "2025 12 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/mangalam-drugs-138636-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Mangalam Drugs and Organics Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-hits-lower-circuit-amid-heavy-selling-pressure-3753915",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MangalamDrugsan_stocks_hitting_lower_circuit_3753915.png",
        "date": "2025-12-09 12:00:08",
        "description": "Mangalam Drugs and Organics Ltd witnessed a sharp decline on 9 December 2025, hitting its lower circuit limit as intense selling pressure gripped the stock. The pharmaceutical company’s shares closed at a new 52-week low of ₹23.55, marking a significant daily loss and reflecting a broader sentiment of panic selling among investors."
      },
      {
        "title": "Mangalam Drugs and Organics Falls to 52-Week Low of Rs.23.77",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-stock-hits-52-week-low-amidst-continued-downtrend-3753862",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MangalamDrugsan_priceRelatedfactors_3753862.png",
        "date": "2025-12-09 11:45:33",
        "description": "Mangalam Drugs and Organics has reached a new 52-week low price of Rs.23.77, marking a significant decline amid ongoing pressures in the Pharmaceuticals & Biotechnology sector. The stock has underperformed its sector peers and broader market indices, reflecting persistent challenges in its financial performance and market valuation."
      },
      {
        "title": "Mangalam Drugs Sees Revision in Market Assessment Amidst Challenging Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mangalam-drugs-downgraded-to-strong-sell-amid-deteriorating-fundamentals-3750080",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MangalamDrugs_mojoScore_3750080.png",
        "date": "2025-12-07 10:10:21",
        "description": "Mangalam Drugs, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting ongoing financial and operational challenges. This shift highlights the company's current standing amid a difficult market environment and deteriorating fundamentals."
      },
      {
        "title": "Mangalam Drugs and Organics Hits Upper Circuit Amid Strong Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-hits-upper-circuit-amid-strong-buying-pressure-3746021",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MangalamDrugsan_stocks_hitting_upper_circuit_3746021.png",
        "date": "2025-12-04 10:00:10",
        "description": "Shares of Mangalam Drugs and Organics Ltd surged to hit the upper circuit limit on 4 December 2025, reflecting robust buying interest and a maximum permissible daily gain of 5%. The stock closed at ₹25.40, marking a significant turnaround after a prolonged period of decline, and outperformed its sector and benchmark indices amid notable market activity."
      },
      {
        "title": "Mangalam Drugs and Organics Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-hits-lower-circuit-amid-heavy-selling-pressure-3743480",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MangalamDrugsan_stocks_hitting_lower_circuit_3743480.png",
        "date": "2025-12-03 10:00:08",
        "description": "Shares of Mangalam Drugs and Organics Ltd plunged to their lower circuit limit on 3 December 2025, reflecting intense selling pressure and a continuation of a prolonged downtrend. The stock recorded its new 52-week low at ₹23.94, marking a significant decline amid subdued investor participation and unfilled supply on the order books."
      },
      {
        "title": "Mangalam Drugs and Organics Falls to 52-Week Low of Rs.24.08 Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-falls-to-52-week-low-amidst-continued-downtrend-3743387",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MangalamDrugsan_priceRelatedfactors_3743387.png",
        "date": "2025-12-03 09:49:24",
        "description": "Mangalam Drugs and Organics has reached a new 52-week low of Rs.24.08, marking a significant decline amid a sustained period of negative returns and financial pressures. The stock’s recent performance highlights ongoing challenges within the Pharmaceuticals & Biotechnology sector, as it continues to trade well below key moving averages and underperform its benchmark indices."
      },
      {
        "title": "Mangalam Drugs and Organics Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-hits-lower-circuit-amid-heavy-selling-pressure-3741645",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MangalamDrugsan_stocks_hitting_lower_circuit_3741645.png",
        "date": "2025-12-02 11:00:12",
        "description": "Mangalam Drugs and Organics Ltd witnessed a sharp decline on 2 Dec 2025, hitting its lower circuit limit as intense selling pressure gripped the stock. The pharmaceutical and biotechnology company’s shares closed at a new 52-week low of Rs 25.20, marking a maximum daily loss of 5.01%, significantly underperforming its sector and the broader market indices."
      },
      {
        "title": "Mangalam Drugs and Organics Faces Intense Selling Pressure Amid Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-faces-severe-selling-pressure-hits-new-52-week-low-3741560",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MangalamDrugsan_only_sellers_3741560.png",
        "date": "2025-12-02 10:30:15",
        "description": "Mangalam Drugs and Organics Ltd is currently experiencing severe selling pressure, marked by a complete absence of buyers and a persistent decline in its share price. The stock has recorded consecutive losses over an extended period, signalling distress selling within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Mangalam Drugs and Organics Falls to 52-Week Low of Rs.25.85 Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-hits-52-week-low-amidst-continued-downtrend-3741094",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MangalamDrugsan_priceRelatedfactors_3741094.png",
        "date": "2025-12-02 09:48:44",
        "description": "Mangalam Drugs and Organics has reached a fresh 52-week low of Rs.25.85, marking a significant decline amid an extended period of negative returns and underperformance relative to its sector and broader market indices."
      }
    ],
    "total": 133,
    "sid": "138636",
    "stock_news_url": "https://www.marketsmojo.com/news/mangalam-drugs-and-organics-138636"
  },
  "announcements": [
    {
      "details": "Mangalam Drugs And Organics Limitedalam Drugs And Organics Limited for the quarter ended 30-Sep-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "Mangalam Drugs And Organics Limited - Reply to Clarification- Financial results",
      "datetime": "09-Dec-2019"
    },
    {
      "details": "Mangalam Drugs And Organics Limitedgs And Organics Limited for the quarter ended 30-Sep-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "Mangalam Drugs And Organics Limited - Clarification - Financial Results",
      "datetime": "21-Nov-2019"
    },
    {
      "details": "Mangalam Drugs And Organics Limited has informed the Exchange regarding Compliance under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "Mangalam Drugs And Organics Limited - Other General Purpose",
      "datetime": "15-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Mangalam Drugs and Organics Ltd has declared <strong>5%</strong> dividend, ex-date: 21 Dec 17",
          "dt": "2017-12-21",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Mangalam Drugs and Organics Hits Lower Circuit Amid Heavy Selling Pressure

2025-12-09 12:00:08

Mangalam Drugs and Organics Ltd witnessed a sharp decline on 9 December 2025, hitting its lower circuit limit as intense selling pressure gripped the stock. The pharmaceutical company’s shares closed at a new 52-week low of ₹23.55, marking a significant daily loss and reflecting a broader sentiment of panic selling among investors.

Mangalam Drugs and Organics Falls to 52-Week Low of Rs.23.77

2025-12-09 11:45:33

Mangalam Drugs and Organics has reached a new 52-week low price of Rs.23.77, marking a significant decline amid ongoing pressures in the Pharmaceuticals & Biotechnology sector. The stock has underperformed its sector peers and broader market indices, reflecting persistent challenges in its financial performance and market valuation.

Mangalam Drugs Sees Revision in Market Assessment Amidst Challenging Financials

2025-12-07 10:10:21

Mangalam Drugs, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting ongoing financial and operational challenges. This shift highlights the company's current standing amid a difficult market environment and deteriorating fundamentals.

Mangalam Drugs and Organics Hits Upper Circuit Amid Strong Buying Pressure

2025-12-04 10:00:10

Shares of Mangalam Drugs and Organics Ltd surged to hit the upper circuit limit on 4 December 2025, reflecting robust buying interest and a maximum permissible daily gain of 5%. The stock closed at ₹25.40, marking a significant turnaround after a prolonged period of decline, and outperformed its sector and benchmark indices amid notable market activity.

Mangalam Drugs and Organics Hits Lower Circuit Amid Heavy Selling Pressure

2025-12-03 10:00:08

Shares of Mangalam Drugs and Organics Ltd plunged to their lower circuit limit on 3 December 2025, reflecting intense selling pressure and a continuation of a prolonged downtrend. The stock recorded its new 52-week low at ₹23.94, marking a significant decline amid subdued investor participation and unfilled supply on the order books.

Mangalam Drugs and Organics Falls to 52-Week Low of Rs.24.08 Amidst Prolonged Downtrend

2025-12-03 09:49:24

Mangalam Drugs and Organics has reached a new 52-week low of Rs.24.08, marking a significant decline amid a sustained period of negative returns and financial pressures. The stock’s recent performance highlights ongoing challenges within the Pharmaceuticals & Biotechnology sector, as it continues to trade well below key moving averages and underperform its benchmark indices.

Mangalam Drugs and Organics Hits Lower Circuit Amid Heavy Selling Pressure

2025-12-02 11:00:12

Mangalam Drugs and Organics Ltd witnessed a sharp decline on 2 Dec 2025, hitting its lower circuit limit as intense selling pressure gripped the stock. The pharmaceutical and biotechnology company’s shares closed at a new 52-week low of Rs 25.20, marking a maximum daily loss of 5.01%, significantly underperforming its sector and the broader market indices.

Mangalam Drugs and Organics Faces Intense Selling Pressure Amid Prolonged Downtrend

2025-12-02 10:30:15

Mangalam Drugs and Organics Ltd is currently experiencing severe selling pressure, marked by a complete absence of buyers and a persistent decline in its share price. The stock has recorded consecutive losses over an extended period, signalling distress selling within the Pharmaceuticals & Biotechnology sector.

Mangalam Drugs and Organics Falls to 52-Week Low of Rs.25.85 Amidst Prolonged Downtrend

2025-12-02 09:48:44

Mangalam Drugs and Organics has reached a fresh 52-week low of Rs.25.85, marking a significant decline amid an extended period of negative returns and underperformance relative to its sector and broader market indices.

View All News